Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: Findings from the Pediatric Cardiomyopathy Registry

Steven D. Colan, Steven E Lipshultz, April M. Lowe, Lynn A. Sleeper, Jane Messere, Gerald F. Cox, Paul R. Lurie, E. John Orav, Jeffrey A. Towbin

Research output: Contribution to journalArticle

241 Citations (Scopus)

Abstract

BACKGROUND - Current information on the epidemiology and outcomes of hypertrophic cardiomyopathy (HCM) in children is limited by disease diversity and small case series. METHODS AND RESULTS - The Pediatric Cardiomyopathy Registry has collected prospective and retrospective data on children diagnosed with HCM since 1990. We identified the various causes of HCM in childhood and determined the relationship between outcomes, cause, and age at presentation. Of 855 patients <18 years of age with HCM, 8.7% (n=74) had inborn errors of metabolism, 9.0% (n=77) had malformation syndromes, 7.5% (n=64) had neuromuscular disorders, and 74.2% (n=634) had idiopathic HCM. Children with HCM associated with inborn errors of metabolism and malformation syndromes have significantly worse survival than the other 2 groups. Patients with idiopathic HCM diagnosed before 1 year of age (n=227) had worse survival from the time of diagnosis than those diagnosed after 1 year of age (n=407). Patients with idiopathic HCM who survived to at least 1 year of age, however, had an annual mortality rate of 1% that was similar regardless of whether they were diagnosed before or after 1 year of age. CONCLUSIONS - In children, HCM is a diverse disorder with outcomes that depend largely on cause and age. Patients presenting before 1 year of age have the broadest spectrum of causes and the poorest outcome. In those children with idiopathic HCM who survive beyond age 1, however, survival is independent of age at diagnosis, with an annual mortality rate (1%) that is much lower than previously reported in children and is not different from has been found in population-based studies in adults.

Original languageEnglish
Pages (from-to)773-781
Number of pages9
JournalCirculation
Volume115
Issue number6
DOIs
StatePublished - Feb 1 2007

Fingerprint

Hypertrophic Cardiomyopathy
Cardiomyopathies
Registries
Epidemiology
Pediatrics
Inborn Errors Metabolism
Survival
Mortality

Keywords

  • Cardiomyopathy
  • Death, sudden
  • Heart diseases
  • Heart failure
  • Hypertrophy
  • Pediatrics
  • Survival

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Colan, S. D., Lipshultz, S. E., Lowe, A. M., Sleeper, L. A., Messere, J., Cox, G. F., ... Towbin, J. A. (2007). Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: Findings from the Pediatric Cardiomyopathy Registry. Circulation, 115(6), 773-781. https://doi.org/10.1161/CIRCULATIONAHA.106.621185

Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children : Findings from the Pediatric Cardiomyopathy Registry. / Colan, Steven D.; Lipshultz, Steven E; Lowe, April M.; Sleeper, Lynn A.; Messere, Jane; Cox, Gerald F.; Lurie, Paul R.; Orav, E. John; Towbin, Jeffrey A.

In: Circulation, Vol. 115, No. 6, 01.02.2007, p. 773-781.

Research output: Contribution to journalArticle

Colan, SD, Lipshultz, SE, Lowe, AM, Sleeper, LA, Messere, J, Cox, GF, Lurie, PR, Orav, EJ & Towbin, JA 2007, 'Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: Findings from the Pediatric Cardiomyopathy Registry', Circulation, vol. 115, no. 6, pp. 773-781. https://doi.org/10.1161/CIRCULATIONAHA.106.621185
Colan, Steven D. ; Lipshultz, Steven E ; Lowe, April M. ; Sleeper, Lynn A. ; Messere, Jane ; Cox, Gerald F. ; Lurie, Paul R. ; Orav, E. John ; Towbin, Jeffrey A. / Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children : Findings from the Pediatric Cardiomyopathy Registry. In: Circulation. 2007 ; Vol. 115, No. 6. pp. 773-781.
@article{56581a62aa30451cb7950721107c20a4,
title = "Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: Findings from the Pediatric Cardiomyopathy Registry",
abstract = "BACKGROUND - Current information on the epidemiology and outcomes of hypertrophic cardiomyopathy (HCM) in children is limited by disease diversity and small case series. METHODS AND RESULTS - The Pediatric Cardiomyopathy Registry has collected prospective and retrospective data on children diagnosed with HCM since 1990. We identified the various causes of HCM in childhood and determined the relationship between outcomes, cause, and age at presentation. Of 855 patients <18 years of age with HCM, 8.7{\%} (n=74) had inborn errors of metabolism, 9.0{\%} (n=77) had malformation syndromes, 7.5{\%} (n=64) had neuromuscular disorders, and 74.2{\%} (n=634) had idiopathic HCM. Children with HCM associated with inborn errors of metabolism and malformation syndromes have significantly worse survival than the other 2 groups. Patients with idiopathic HCM diagnosed before 1 year of age (n=227) had worse survival from the time of diagnosis than those diagnosed after 1 year of age (n=407). Patients with idiopathic HCM who survived to at least 1 year of age, however, had an annual mortality rate of 1{\%} that was similar regardless of whether they were diagnosed before or after 1 year of age. CONCLUSIONS - In children, HCM is a diverse disorder with outcomes that depend largely on cause and age. Patients presenting before 1 year of age have the broadest spectrum of causes and the poorest outcome. In those children with idiopathic HCM who survive beyond age 1, however, survival is independent of age at diagnosis, with an annual mortality rate (1{\%}) that is much lower than previously reported in children and is not different from has been found in population-based studies in adults.",
keywords = "Cardiomyopathy, Death, sudden, Heart diseases, Heart failure, Hypertrophy, Pediatrics, Survival",
author = "Colan, {Steven D.} and Lipshultz, {Steven E} and Lowe, {April M.} and Sleeper, {Lynn A.} and Jane Messere and Cox, {Gerald F.} and Lurie, {Paul R.} and Orav, {E. John} and Towbin, {Jeffrey A.}",
year = "2007",
month = "2",
day = "1",
doi = "10.1161/CIRCULATIONAHA.106.621185",
language = "English",
volume = "115",
pages = "773--781",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children

T2 - Findings from the Pediatric Cardiomyopathy Registry

AU - Colan, Steven D.

AU - Lipshultz, Steven E

AU - Lowe, April M.

AU - Sleeper, Lynn A.

AU - Messere, Jane

AU - Cox, Gerald F.

AU - Lurie, Paul R.

AU - Orav, E. John

AU - Towbin, Jeffrey A.

PY - 2007/2/1

Y1 - 2007/2/1

N2 - BACKGROUND - Current information on the epidemiology and outcomes of hypertrophic cardiomyopathy (HCM) in children is limited by disease diversity and small case series. METHODS AND RESULTS - The Pediatric Cardiomyopathy Registry has collected prospective and retrospective data on children diagnosed with HCM since 1990. We identified the various causes of HCM in childhood and determined the relationship between outcomes, cause, and age at presentation. Of 855 patients <18 years of age with HCM, 8.7% (n=74) had inborn errors of metabolism, 9.0% (n=77) had malformation syndromes, 7.5% (n=64) had neuromuscular disorders, and 74.2% (n=634) had idiopathic HCM. Children with HCM associated with inborn errors of metabolism and malformation syndromes have significantly worse survival than the other 2 groups. Patients with idiopathic HCM diagnosed before 1 year of age (n=227) had worse survival from the time of diagnosis than those diagnosed after 1 year of age (n=407). Patients with idiopathic HCM who survived to at least 1 year of age, however, had an annual mortality rate of 1% that was similar regardless of whether they were diagnosed before or after 1 year of age. CONCLUSIONS - In children, HCM is a diverse disorder with outcomes that depend largely on cause and age. Patients presenting before 1 year of age have the broadest spectrum of causes and the poorest outcome. In those children with idiopathic HCM who survive beyond age 1, however, survival is independent of age at diagnosis, with an annual mortality rate (1%) that is much lower than previously reported in children and is not different from has been found in population-based studies in adults.

AB - BACKGROUND - Current information on the epidemiology and outcomes of hypertrophic cardiomyopathy (HCM) in children is limited by disease diversity and small case series. METHODS AND RESULTS - The Pediatric Cardiomyopathy Registry has collected prospective and retrospective data on children diagnosed with HCM since 1990. We identified the various causes of HCM in childhood and determined the relationship between outcomes, cause, and age at presentation. Of 855 patients <18 years of age with HCM, 8.7% (n=74) had inborn errors of metabolism, 9.0% (n=77) had malformation syndromes, 7.5% (n=64) had neuromuscular disorders, and 74.2% (n=634) had idiopathic HCM. Children with HCM associated with inborn errors of metabolism and malformation syndromes have significantly worse survival than the other 2 groups. Patients with idiopathic HCM diagnosed before 1 year of age (n=227) had worse survival from the time of diagnosis than those diagnosed after 1 year of age (n=407). Patients with idiopathic HCM who survived to at least 1 year of age, however, had an annual mortality rate of 1% that was similar regardless of whether they were diagnosed before or after 1 year of age. CONCLUSIONS - In children, HCM is a diverse disorder with outcomes that depend largely on cause and age. Patients presenting before 1 year of age have the broadest spectrum of causes and the poorest outcome. In those children with idiopathic HCM who survive beyond age 1, however, survival is independent of age at diagnosis, with an annual mortality rate (1%) that is much lower than previously reported in children and is not different from has been found in population-based studies in adults.

KW - Cardiomyopathy

KW - Death, sudden

KW - Heart diseases

KW - Heart failure

KW - Hypertrophy

KW - Pediatrics

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=33847103768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847103768&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.106.621185

DO - 10.1161/CIRCULATIONAHA.106.621185

M3 - Article

C2 - 17261650

AN - SCOPUS:33847103768

VL - 115

SP - 773

EP - 781

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 6

ER -